Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic shifts, a consequence of hyperosmolarity, are a hallmark of mental disorders.

Journal of psychiatric research·2026
Same author

Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Singlet Oxygen-Induced Mitochondrial Reset in Cancer: A Novel Approach for Ovarian Cancer Therapy.

Metabolites·2024
Same author

Metabolic modelling links Warburg effect to collagen formation, angiogenesis and inflammation in the tumoral stroma.

PloS one·2024
Same author

In Vitro Methylene Blue and Carboplatin Combination Triggers Ovarian Cancer Cells Death.

International journal of molecular sciences·2024
Same author

Metabolic Shift and Hyperosmolarity Underlie Age-Related Macular Degeneration.

Life (Basel, Switzerland)·2024

Related Experiment Video

Updated: Jun 26, 2026

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

Carbon dioxide inhalation causes pulmonary inflammation.

Mohammad Abolhassani1, Adeline Guais, Philippe Chaumet-Riffaud

  • 1Service de Radiothérapie Hôpital Pitié-Salpétrière, 75013 Paris, France.

American Journal of Physiology. Lung Cellular and Molecular Physiology
|January 13, 2009
PubMed
Summary

High carbon dioxide (CO2) levels trigger inflammation by activating cellular pathways. This suggests CO2 may be more toxic than previously understood, with implications for combustion-related health risks.

More Related Videos

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

Related Experiment Videos

Last Updated: Jun 26, 2026

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

Area of Science:

  • Environmental Health
  • Cellular Biology
  • Toxicology

Background:

  • Carbon dioxide (CO2) is a common atmospheric gas involved in cellular respiration.
  • Its potential role as a proinflammatory agent is not well understood.

Purpose of the Study:

  • To investigate if carbon dioxide (CO2) exposure induces an inflammatory response in vitro and in vivo.
  • To elucidate the molecular mechanisms underlying CO2-induced inflammation.

Main Methods:

  • In vitro exposure of epithelial cell lines and primary pulmonary cells to varying CO2 concentrations.
  • In vivo exposure of mice to increasing CO2 levels.
  • Analysis of proinflammatory cytokine transcription and secretion (ELISA, RNase protection assay).
  • Assessment of lung inflammation markers (mucin 5AC) and airway hyperreactivity.
  • Investigation of the role of NF-kappaB and protein phosphatase 2A (PP2A) signaling pathways.

Main Results:

  • CO2 concentrations above 5% significantly increased the secretion of multiple proinflammatory cytokines.
  • In vivo studies showed enhanced mucin 5AC production and airway hyperreactivity in mice exposed to CO2.
  • CO2-induced inflammation was mediated by PP2A activation and subsequent p65 NF-kappaB nuclear translocation.
  • siRNA-mediated inhibition of PP2Ac reversed the inflammatory effects of CO2.

Conclusions:

  • Exposure to elevated carbon dioxide levels can induce significant proinflammatory responses.
  • The findings suggest CO2 may be more toxic than previously recognized.
  • This research has potential implications for understanding the health risks associated with combustion products.